Tramadol hydrochloride resistance can be rotated with other medications under the guidance of a specialist, such as buprenorphine transdermal patches.
Generally most medications that act on opioid receptor medications will develop dependence or resistance. Tramadol hydrochloride binds less to opioid receptor drugs than morphine, so the risk of dependence and resistance is dramatically reduced.
If resistance occurs during standardized use of tramadol hydrochloride, it may be possible to reduce the resistance to the drug by rotating the drug under the supervision of a specialist, for example, with buprenorphine transdermal patches.
Adverse effects of tramadol hydrochloride include sweating, dizziness, vomiting, itching, and fatigue, and it is contraindicated in people who are highly sensitive to tramadol hydrochloride.
In addition, the use of Tramadol Hydrochloride carries certain risks and patients need to be supervised by a specialist.